Cargando…
2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases
Premature termination codons (PTCs) account for 10 to 20% of genetic diseases in humans. The gene inactivation resulting from PTCs can be counteracted by the use of drugs stimulating PTC readthrough, thereby restoring production of the full-length protein. However, a greater chemical variety of read...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436315/ https://www.ncbi.nlm.nih.gov/pubmed/35994666 http://dx.doi.org/10.1073/pnas.2122004119 |